EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Natural tyrosinase enzyme inhibitors: A path from melanin to melanoma and its reported pharmacological activities

Rajan Logesh, Sagar Rajendra Prasad, Sandhya Chipurupalli, Nirmal Robinson, Suresh Kumar Mohankumar

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2023

DOI: 10.1016/j.bbcan.2023.188968 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023. Verfasst von Rajan Logesh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru 570015, Karnataka, India. Electronic addre…. Hauptthemen laut MEDLINE: Melanins, Melanoma. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 296 Literaturangaben. Gefördert von: JSS Academy of Higher Education and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The skin containing melanin pigment acts as a protective barrier and counteracts the UVR and other environmental stressors to maintain or restore disrupted cutaneous homeostasis. The production of melanin pigment is dependent on tyrosine levels. L-tyrosine and L-dihydroxyphenylalanine (L-DOPA) can serve both as a substrates and intermediates of melanin synthetic pathway and as inducers and positive regulators of melanogenesis. The biosynthesis of melanin is stimulated upon exposure to UVR, which can also stimulate local production of hormonal factors, which can stimulate melanoma development by altering the chemical properties of eu- and pheomelanin. The process of melanogenesis can be altered by several pathways. One involves activation of POMC, with the production of POMC peptides including MSH and ACTH, which increase intracellular cAMP levels, which activates the MITF, and helps to stimulate tyrosinase (TYR) expression and activity. Defects in OCA1 to 4 affects melanogenic activity via posttranslational modifications resulting in proteasomal degradation and reducing pigmentation. Further, altering, the MITF factor, helps to regulate the expression of MRGE in melanoma, and helps to increase the TYR glycosylation in ER. CRH stimulates POMC peptides that regulate melanogenesis and also by itself can stimulate melanogenesis. The POMC, P53, ACTH, MSH, MC1R, MITF, and 6-BH4 are found to be important regulators for pigmentation. Melanogenesis can affect melanoma behaviour and inhibit immune responses. Therefore, we reviewed natural products that would alter melanin production. Our special focus was on targeting melanin synthesis and TYR enzyme activity to inhibit melanogenesis as an adjuvant therapy of melanotic melanoma. Furthermore, this review also outlines the current updated pharmacological studies targeting the TYR enzyme from natural sources and its consequential effects on melanin production.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelaninsMelanomaHumansMonophenol MonooxygenasePro-OpiomelanocortinCell Line, TumorTyrosineEnzyme InhibitorsAdrenocorticotropic Hormone

Stichwörter der Autor:innen

MelaninMelanogenesisMelanomaSkin cancerSkin pigmentationTyrosinase inhibitors

Substanzen

MelaninsMonophenol MonooxygenasePro-OpiomelanocortinTyrosineEnzyme InhibitorsAdrenocorticotropic Hormone

Autor:innen und Institutionen

  • Department of Pharmacognosy, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru 570015, Karnataka, India. Electronic address: logeshr@jssuni.edu.in.
  • Department of Pharmacognosy, Varadaraja Institute of Pharmaceutical Education and Research, Tumkur 572102, Karnataka, India.
  • Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, India.
  • Cellular Stress and Immune Response Laboratory, Centre for Cancer Biology, University of South Australia, Adelaide, Australia.
  • Pharmacy, Swansea University Medical School, Singleton Park, Swansea University, Wales SA2 8PP, United Kingdom.

Förderung

  • JSS Academy of Higher Education and Research

Zitieren

APA

Logesh, R., Prasad, S. R., Chipurupalli, S., Robinson, N., & Mohankumar, S. K. (2023). Natural tyrosinase enzyme inhibitors: A path from melanin to melanoma and its reported pharmacological activities. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2023.188968

Vancouver

Logesh R, Prasad SR, Chipurupalli S, Robinson N, Mohankumar SK. Natural tyrosinase enzyme inhibitors: A path from melanin to melanoma and its reported pharmacological activities. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023. doi:10.1016/j.bbcan.2023.188968

BibTeX
@article{Logesh2023,
  author = {Logesh, Rajan and Prasad, Sagar Rajendra and Chipurupalli, Sandhya and Robinson, Nirmal and Mohankumar, Suresh Kumar},
  title = {Natural tyrosinase enzyme inhibitors: A path from melanin to melanoma and its reported pharmacological activities},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2023},
  doi = {10.1016/j.bbcan.2023.188968}
}
Kostenlos starten →